Below are the most recent publications written about "Asymptomatic Infections" by people in Profiles.
-
Bradley ES, Stansky C, Zeamer AL, Huang Z, Cincotta L, Lopes A, Potter L, Fontes T, Ward DV, Bucci V, McCormick BA, Haran JP. The urinary microbiome distinguishes symptomatic urinary tract infection from asymptomatic older adult patients presenting to the emergency department. Virulence. 2025 Dec; 16(1):2546063.
-
Seth MD, Popkin-Hall ZR, Madebe RA, Budodo R, Bakari C, Lyimo BM, Giesbrecht D, Moshi R, Mbwambo RB, Francis F, Pereus D, Mbata D, Challe DP, Mandai SS, Chacha GA, Kisambale AJ, Mbwambo D, Aaron S, Lusasi A, Lazaro S, Mandara CI, Bailey JA, Juliano JJ, Gutman JR, Ishengoma DS. Prevalence of subpatent Plasmodium falciparum infections in regions with varying transmission intensities and implications for malaria elimination in Mainland Tanzania. Malar J. 2025 Mar 26; 24(1):101.
-
Almeida GG, Costa CM, Costa PAC, Gomes GR, Figueiredo MM, Torres KJ, de Carvalho AF, Valiate BVS, Sampaio JR, Carvalho BC, Pereira DB, Martines A, Tada MS, Soares IS, Ponmattam J, Castro MC, Golenbock DT, Gazzinelli RT, Antonelli LRDV. Asymptomatic vivax malaria is associated with an IFN-?-program on adaptive immunity. J Transl Med. 2025 Mar 19; 23(1):351.
-
Tukwasibwe S, Garg S, Katairo T, Asua V, Kagurusi BA, Mboowa G, Crudale R, Tumusiime G, Businge J, Alula D, Kasozi J, Wadembere I, Ssewanyana I, Arinaitwe E, Nankabirwa JI, Nsobya SL, Kamya MR, Greenhouse B, Dorsey G, Bailey JA, Briggs J, Conrad MD, Rosenthal PJ. Varied Prevalence of Antimalarial Drug Resistance Markers in Different Populations of Newly Arrived Refugees in Uganda. J Infect Dis. 2024 Aug 16; 230(2):497-504.
-
Popkin-Hall ZR, Seth MD, Madebe RA, Budodo R, Bakari C, Francis F, Pereus D, Giesbrecht DJ, Mandara CI, Mbwambo D, Aaron S, Lusasi A, Lazaro S, Bailey JA, Juliano JJ, Gutman JR, Ishengoma DS. Prevalence of non-falciparum malaria infections among asymptomatic individuals in four regions of Mainland Tanzania. Parasit Vectors. 2024 Mar 23; 17(1):153.
-
Andolina C, Ramjith J, Rek J, Lanke K, Okoth J, Grignard L, Arinaitwe E, Briggs J, Bailey J, Aydemir O, Kamya MR, Greenhouse B, Dorsey G, Staedke SG, Drakeley C, Jonker M, Bousema T. Plasmodium falciparum gametocyte carriage in longitudinally monitored incident infections is associated with duration of infection and human host factors. Sci Rep. 2023 05 01; 13(1):7072.
-
Wamae K, Kimenyi KM, Osoti V, de Laurent ZR, Ndwiga L, Kharabora O, Hathaway NJ, Bailey JA, Juliano JJ, Bejon P, Ochola-Oyier LI. Amplicon Sequencing as a Potential Surveillance Tool for Complexity of Infection and Drug Resistance Markers in Plasmodium falciparum Asymptomatic Infections. J Infect Dis. 2022 09 13; 226(5):920-927.
-
Almeida GG, Costa PAC, Araujo MDS, Gomes GR, Carvalho AF, Figueiredo MM, Pereira DB, Tada MS, Medeiros JF, Soares IDS, Carvalho LH, Kano FS, Castro MC, Vinetz JM, Golenbock DT, Antonelli LRDV, Gazzinelli RT. Asymptomatic Plasmodium vivax malaria in the Brazilian Amazon: Submicroscopic parasitemic blood infects Nyssorhynchus darlingi. PLoS Negl Trop Dis. 2021 10; 15(10):e0009077.
-
Silverstein NJ, Luban J. Lessons from a local effort to screen for SARS-CoV-2. Proc Natl Acad Sci U S A. 2021 06 29; 118(26).
-
Salje H, Alera MT, Chua MN, Hunsawong T, Ellison D, Srikiatkhachorn A, Jarman RG, Gromowski GD, Rodriguez-Barraquer I, Cauchemez S, Cummings DAT, Macareo L, Yoon IK, Fernandez S, Rothman AL. Evaluation of the extended efficacy of the Dengvaxia vaccine against symptomatic and subclinical dengue infection. Nat Med. 2021 08; 27(8):1395-1400.